Back
4 MIN READ
The global cannabis industry presents investors with the investment opportunities not seen in many years.
The market has never encountered an opportunity like that of the cannabis industry and we expect the industry to witness a growth cycle that is more significant than the technology boom during the 90s.
If you want to understand the opportunities in this emerging industry, all you must do is read. The cannabis sector is comprised of more than 400 publicly traded companies and there is a rarely a quiet day in the sector.
Canada has provided investors with several of the best cannabis investments and we are favorable on many of these opportunities due to the upcoming legalization of recreational cannabis at the federal level.
The Canadian cannabis sector is comprised of several industry leaders and we want to provide an update on important developments in this sector during January.
- Canopy Growth (WEED.TO: TSX) completed its acquisition of Mettrum Health and changed its trading symbol to “WEED” on the TSX exchange. The combination of the two businesses will create a globally diversified cannabis company that has six licensed facilities and a licensed production footprint of approximately 665,000 sq. ft. with significant acreage for expansion.
- The Green Organic Dutchman (private) sent out the certificates for the financing round that closed in December. This licensed Canadian cannabis producer plans to go public in the back half of 2017 and will be exhibiting at The Orlando MoneyShow next week! Reach out to support@mushroomstocks.com to learn how to get involved with this private investment opportunity.
- Emblem Corp. (EMC.V: TSX Venture) (EMMBF: OTC) closed its previously announced bought deal private placement of 4,385,668 special warrants at $3.63 a share. The company raised almost $16 million and plans to use the proceeds for its planned facility expansion and general corporate purposes.
- In early January, Aurora Cannabis (ACB.V: TSX Venture) (ACBFF: OTC) and Radient Technologies (RTI.V: TSX Venture) formed a joint venture to confirm the effectiveness of Radient’s MAP technology for cannabis extraction. Initial work under the study is ongoing and the companies will provide a further update when Aurora makes its final determination in regards to its investment in the debenture (previously agreed to invest up to $2 million).
- Organigram Holdings (OGI.V) (OGRMF) reported tremendous growth when it announced financial results earlier this month. When compared to the same quarter last year, Organigram sold 82% more grams of cannabis flower and sales increased by more than 120% during this time. The company also provided an update about its recent voluntary recall, the quantified impact to its financial statements as well as some of the immediate and voluntary corrective actions and policies that have since been implemented.
Important Investor Disclosures Disclosure. Compensated Affiliate. This report was authored by and is property of StoneBridge Partners LLC. All information and data relied upon in drafting this report is publicly available. The author believes and considers its sources to be reliable, but does not guarantee the accuracy or completeness of any information contained in this report. Any and all information, data, analyses and opinions are provided for informational purposes only and is not intended, in any manner, as investment advice. Any projections or other information generated by StoneBridge Partners LLC regarding the likelihood of various investment outcomes are hypothetical in nature, do not reflect actual investment results, and are not guarantees of future results. None of the material contained in this report is intended as a solution or offer to sell or purchase a specific stock or any other investment. This report is not directed to, or intended for distribution or use by, any person or entity that is a citizen, resident or located in any municipality, state, country or other jurisdiction where the distribution, publication, availability, or use of this report is contrary to any governing law or regulation. The securities discussed in this report may not be eligible for purchase and/or sale in certain jurisdictions or by particular individuals. It is important that you check any and all governing laws and/or regulations that may be applicable in your jurisdiction. Investing in securities of issuers organized outside of the United States, including ADRs, entail certain risks. The securities of non-United States issuers may not be registered with, nor be subject to the reporting requirements of the United States Securities and Exchange Commission. Please contact a Financial Advisor for professional advice regarding any and all securities investments. This report is intended for informational purposes only. StoneBridge Partners LLC’s officers, directors, employees, affiliates, or subsidiaries may have positions in securities covered by StoneBridge Partners LLC. StoneBridge Partners LLC receives compensation from the company and/or has a position in the securities mentioned in this report
All good -- no spamming here.
Comments